4//SEC Filing
Wasoff Evan L 4
Accession 0001214659-24-010004
CIK 0001625288other
Filed
May 27, 8:00 PM ET
Accepted
May 28, 11:57 AM ET
Size
8.6 KB
Accession
0001214659-24-010004
Insider Transaction Report
Form 4
Wasoff Evan L
Chief Financial Officer
Transactions
- Award
Common stock
2024-05-23+2,000,000→ 6,500,000 total
Holdings
- 200,000
Options to purchase common stock (right to buy)
Exercise: $0.66From: 2018-10-26Exp: 2025-10-26→ common stock (200,000 underlying) - 1,500,000
Options to purchase common stock (right to buy)
Exercise: $0.08From: 2020-08-19Exp: 2027-08-19→ common stock (1,500,000 underlying) - 420,000
Options to purchase common stock (right to buy)
Exercise: $0.54From: 2018-07-25Exp: 2025-07-25→ common stock (420,000 underlying)
Footnotes (1)
- [F1]Issued in lieu of compensation for services.
Documents
Issuer
NEXIEN BIOPHARMA, INC.
CIK 0001625288
Entity typeother
Related Parties
1- filerCIK 0001719738
Filing Metadata
- Form type
- 4
- Filed
- May 27, 8:00 PM ET
- Accepted
- May 28, 11:57 AM ET
- Size
- 8.6 KB